×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

IBM to Acquire Confluent for $11 Billion in Cash

  • December 8, 2025

IBM - Confluent Merger

International Business Machines Corporation (IBM) entered a merger agreement on December 8, 2025, to acquire Confluent, Inc. (CFLT) in an all-cash deal valued at $11 billion.

Deal Structure:

IBM will acquire all of the issued and outstanding common shares of Confluent for $31 per share in cash, representing a premium of 33.97% from the stock’s last close.

Company Profile:

Confluent is a cloud-native data streaming platform that enables organizations to connect, process, and govern real-time data across their operations. It provides Confluent Cloud and Confluent Platform, built on Apache Kafka, to serve as the foundational infrastructure for data.

IBM is a global leader in hybrid cloud, AI, and consulting, providing integrated software, infrastructure, and services that help organizations modernize operations, unlock data insights, and drive secure digital transformation across industries worldwide.

Deal Details and Timeline:

In October, Reuters reported that Confluent was exploring a sale after attracting acquisition interest. The stock was trading at $20.73 before it was revealed that the company was working with an investment bank on the sale process.

The acquisition of Confluent will be funded entirely with available cash on hand.

The deal is expected to close by the middle of 2026.

IBM is paying 9.08 times sales for Confluent.

Deal Metrics:

For further information regarding this merger and acquisition transaction, visit the Deal Metrics page at this link:

Deal Metrics for the acquisition of Confluent, Inc. (CFLT) by International Business Machines Corporation (IBM)

The Deal Metrics page for each merger or acquisition includes:

  • A historical chart of the merger spread from announcement to completion or failure.
  • Detailed events of the merger progress, including expiration of the HSR period, regulatory approvals, shareholder votes, and the like.
  • Access to news and SEC filings related to the merger.
  • A history of deal updates.
  • And much more.

Disclaimer: Please conduct your own due diligence before buying or selling any securities mentioned in this article. We cannot guarantee the completeness or accuracy of the content or data provided in this article.

Editor’s Note: Baranjot Kaur contributed to this article